[1]
2026. METABOLIC AND HORMONAL RISK FACTORS FOR ENDOMETRIAL HYPERPLASIA IN REPRODUCTIVE-AGE WOMEN: A CRITICAL INTEGRATIVE REVIEW OF PATHOBIOLOGY, REAL-WORLD EVIDENCE AND PRECISION RISK ASSESSMENT. INTERNATIONAL CONFERENCE ON ADVANCE SCIENCE AND TECHNOLOGY. 3, 5 (Oct. 2026), 114–140.